A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer’s,…
Read More »EarlyStage
When treated with a novel protein function inhibitor called ESI1, mice that mimic the symptoms of multiple sclerosis (MS) and…
Read More »Venture capital firm Prudence has raised and closed on an $80 million tranche to back early-stage technology companies targeting the…
Read More »